Specifically, the program uses three locally-tailored, patient-centric models:
- Shared contribution, in which national or provincial governments and other entities share the cost of treatment with Novartis;
- Co-pay, in which the patient shares the cost of treatment with Novartis; and
- Full donation of certain products.
We believe that through this partnership-based approach, we can extend affordable access to a broader number of patients in a sustainable manner.
Today, NOA offers assistance to patients in developing countries in Asia, the Middle East, Central and Eastern Europe, Africa and Latin America.